Lixiang Yu

981 total citations
42 papers, 534 citations indexed

About

Lixiang Yu is a scholar working on Oncology, Epidemiology and Pathology and Forensic Medicine. According to data from OpenAlex, Lixiang Yu has authored 42 papers receiving a total of 534 indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Oncology, 11 papers in Epidemiology and 10 papers in Pathology and Forensic Medicine. Recurrent topics in Lixiang Yu's work include Cancer Risks and Factors (9 papers), Global Cancer Incidence and Screening (9 papers) and Breast Lesions and Carcinomas (9 papers). Lixiang Yu is often cited by papers focused on Cancer Risks and Factors (9 papers), Global Cancer Incidence and Screening (9 papers) and Breast Lesions and Carcinomas (9 papers). Lixiang Yu collaborates with scholars based in China, Cyprus and Sweden. Lixiang Yu's co-authors include Zhigang Yu, Liyuan Liu, Zhongbing Ma, Fei Zhou, Dezong Gao, Liang Li, Yujuan Xiang, Fei Wang, Jie Li and Yuyang Li and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and BMC Public Health.

In The Last Decade

Lixiang Yu

40 papers receiving 522 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Lixiang Yu China 15 229 142 131 110 82 42 534
Dezong Gao China 12 248 1.1× 104 0.7× 44 0.3× 57 0.5× 27 0.3× 19 450
Stefanos Zervoudis Greece 11 178 0.8× 174 1.2× 64 0.5× 60 0.5× 35 0.4× 55 665
Christopher D. Clay Australia 11 163 0.7× 134 0.9× 51 0.4× 36 0.3× 166 2.0× 12 463
Zhongbing Ma China 11 190 0.8× 102 0.7× 40 0.3× 35 0.3× 23 0.3× 17 360
John Zadnick United States 12 220 1.0× 107 0.8× 35 0.3× 32 0.3× 138 1.7× 19 543
Caterina Mancusi Italy 12 113 0.5× 107 0.8× 74 0.6× 58 0.5× 13 0.2× 22 520
Sabas Carlos Vieira Brazil 10 101 0.4× 65 0.5× 36 0.3× 53 0.5× 34 0.4× 71 410
Noel S. Weiss United States 10 346 1.5× 91 0.6× 95 0.7× 36 0.3× 56 0.7× 14 679
Grace Makari‐Judson United States 14 295 1.3× 22 0.2× 137 1.0× 61 0.6× 78 1.0× 33 638

Countries citing papers authored by Lixiang Yu

Since Specialization
Citations

This map shows the geographic impact of Lixiang Yu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lixiang Yu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lixiang Yu more than expected).

Fields of papers citing papers by Lixiang Yu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lixiang Yu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lixiang Yu. The network helps show where Lixiang Yu may publish in the future.

Co-authorship network of co-authors of Lixiang Yu

This figure shows the co-authorship network connecting the top 25 collaborators of Lixiang Yu. A scholar is included among the top collaborators of Lixiang Yu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lixiang Yu. Lixiang Yu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Chen, Lin, Linfeng Zhao, Zhongbing Ma, et al.. (2025). Toremifene exerts chemopreventive effects against breast cancer through MTHFD1L suppression and ROS-mediated apoptosis. Chinese Medical Journal.
2.
Sun, Yaoyao, et al.. (2025). Effects of mindfulness-based interventions on cognitive impairment in patients with cancer: A systematic review and meta-analysis. International Journal of Clinical and Health Psychology. 25(2). 100576–100576. 2 indexed citations
3.
Wang, Di, Weihua Pan, Lijuan Hou, et al.. (2025). The efficacy of psychosocial interventions on anxiety and depression in cancer caregivers: a network meta-analysis. Supportive Care in Cancer. 33(6). 513–513. 1 indexed citations
4.
Zhou, Fei, Liyuan Liu, Fei Wang, et al.. (2024). Periductal Mastitis, a Disease with Distinct Clinicopathological Features from Granulomatous Lobular Mastitis. Journal of Inflammation Research. Volume 17. 3815–3823. 1 indexed citations
5.
Zheng, Chao, Lixiang Yu, Linfeng Zhao, et al.. (2024). Label-free Raman spectroscopy reveals tumor microenvironmental changes induced by intermittent fasting for the prevention of breast cancer in animal model. Spectrochimica Acta Part A Molecular and Biomolecular Spectroscopy. 317. 124387–124387. 1 indexed citations
6.
Zhang, Jialin, Changhua Ji, Wang Fei, et al.. (2024). Pyrotinib is effective in both trastuzumab-sensitive and primary resistant HER2-positive breast tumors. Chinese Journal of Cancer Research. 36(2). 124–137. 5 indexed citations
7.
Liu, Liyuan, Fu De Yang, Fei Wang, et al.. (2023). An Improved Training Algorithm Based on Ensemble Penalized Cox Regression for Predicting Absolute Cancer Risk. China CDC Weekly. 5(9). 206–212.
8.
Bao, Heling, Liyuan Liu, Shu Cong, et al.. (2023). Breast Cancer Awareness and Association with Frequency of Screening Among Women — China, 2020. China CDC Weekly. 5(15). 327–332. 7 indexed citations
9.
Liu, Liyuan, Heling Bao, Fei Wang, et al.. (2023). Depressive Symptoms and Sleep Duration as Risk Factors for Breast Cancer — China, 2020. China CDC Weekly. 5(15). 333–339. 3 indexed citations
10.
Zhou, Fei, Huanjie Li, Fei Wang, et al.. (2023). Efficacy and safety of rifampicin-based triple therapy for non-puerperal mastitis: A single-arm, open-label, prospective clinical trial. International Journal of Infectious Diseases. 140. 25–30. 5 indexed citations
11.
Wang, Yongjiu, Fei Wang, Lixiang Yu, et al.. (2021). Worldwide review with meta-analysis of women’s awareness about breast cancer. Patient Education and Counseling. 105(7). 1818–1827. 23 indexed citations
12.
Li, Liang, Liyuan Liu, Fei Wang, et al.. (2020). Adipocyte-derived SFRP5 inhibits breast cancer cells migration and invasion through Wnt and epithelial-mesenchymal transition signaling pathways. Chinese Journal of Cancer Research. 32(3). 347–360. 19 indexed citations
13.
Zhou, Fei, Lu Liu, Liyuan Liu, et al.. (2019). Comparison of Conservative versus Surgical Treatment Protocols in Treating Idiopathic Granulomatous Mastitis: A Meta-Analysis. Breast Care. 15(4). 415–420. 33 indexed citations
14.
Wang, Lu, Liyuan Liu, Zhen Lou, et al.. (2019). Risk prediction for breast Cancer in Han Chinese women based on a cause-specific Hazard model. BMC Cancer. 19(1). 128–128. 16 indexed citations
15.
Liu, Liyuan, Yongjiu Wang, Fei Wang, et al.. (2018). Factors associated with insufficient awareness of breast cancer among women in Northern and Eastern China: a case–control study. BMJ Open. 8(2). e018523–e018523. 28 indexed citations
16.
Liu, Lu, Fei Zhou, Xiaoxia Zhang, et al.. (2018). Granulomatous Lobular Mastitis: Antituberculous Treatment and Outcome in 22 Patients. Breast Care. 13(5). 359–363. 15 indexed citations
17.
18.
Zhou, Fei, Pin Wang, Lixiang Yu, et al.. (2017). Periductal Mastitis: An Inflammatory Disease Related to Bacterial Infection and Consequent Immune Responses?. Mediators of Inflammation. 2017. 1–9. 33 indexed citations
19.
Yu, Lixiang, Nannan Zhou, Liyuan Liu, et al.. (2014). Adiponectin Receptor 1 (ADIPOR1) rs1342387 Polymorphism and Risk of Cancer: a Meta-analysis. Asian Pacific Journal of Cancer Prevention. 15(18). 7515–7520. 5 indexed citations
20.
Liu, Liyuan, Meng Wang, Zhongbing Ma, et al.. (2013). The Role of Adiponectin in Breast Cancer: A Meta-Analysis. PLoS ONE. 8(8). e73183–e73183. 53 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Dezong Gao Breakdown of academic impact, for papers by Stefanos Zervoudis Breakdown of academic impact, for papers by Christopher D. Clay Breakdown of academic impact, for papers by Zhongbing Ma Breakdown of academic impact, for papers by John Zadnick Breakdown of academic impact, for papers by Caterina Mancusi Breakdown of academic impact, for papers by Sabas Carlos Vieira Breakdown of academic impact, for papers by Noel S. Weiss Breakdown of academic impact, for papers by Grace Makari‐Judson
Rankless by CCL
2026